Dataset Information


Webb2002 - Fas/FasL mediated tumor T-cell interaction

ABSTRACT: Webb2002 - Fas/FasL mediated tumor T-cell interaction This deterministic model of immunological surveillance involving tumour cell–T-lymphocyte interaction, cell surface expression of Fas/FasL, and their secreted soluble forms. This model is described in the article: Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. Webb SD, Sherratt JA, Fish RG. Math Biosci 2002 Sep-Oct; 179(2): 113-129 Abstract: One proposed mechanism of tumour escape from immune surveillance is tumour up-regulation of the cell surface ligand FasL, which can lead to apoptosis of Fas receptor (Fas) positive lymphocytes. Based upon this 'counterattack', we have developed a mathematical model involving tumour cell-lymphocyte interaction, cell surface expression of Fas/FasL, and their secreted soluble forms. The model predicts that (a) the production of soluble forms of Fas and FasL will lead to the down-regulation of the immune response; (b) matrix metalloproteinase (MMP) inactivation should lead to increased membrane FasL and result in a higher rate of Fas-mediated apoptosis for lymphocytes than for tumour cells. Recent studies on cancer patients lend support for these predictions. The clinical implications are two-fold. Firstly, the use of broad spectrum MMP inhibitors as anti-angiogenic agents may be compromised by their adverse effect on tumour FasL up-regulation. Also, Fas/FasL interactions may have an impact on the outcome of numerous ongoing immunotherapeutic trials since the final common pathway of all these approaches is the transduction of death signals within the tumour cell. This model is hosted on BioModels Database and identified by: BIOMD0000000661. To cite BioModels Database, please use: Chelliah V et al. BioModels: ten-year anniversary. Nucl. Acids Res. 2015, 43(Database issue):D542-8. To the extent possible under law, all copyright and related or neighbouring rights to this encoded model have been dedicated to the public domain worldwide. Please refer to CC0 Public Domain Dedication for more information.

SUBMITTER: Camille Laibe  

PROVIDER: BIOMD0000000661 | BioModels | 2017-09-07


altmetric image


Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Suda T T   Takahashi T T   Golstein P P   Nagata S S  

Cell 19931201 6

The Fas antigen (Fas) belongs to the tumor necrosis factor (TNF)/nerve growth factor receptor family, and it mediates apoptosis. Using a soluble form of mouse Fas, prepared by fusion with human immunoglobulin Fc, Fas ligand was detected on the cell surface of a cytotoxic T cell hybridoma, PC60-d10S. A cell population that highly expresses Fas ligand was sorted using a fluorescence-activated cell sorter, and its cDNA was isolated from the sorted cells by expression cloning. The amino acid sequenc  ...[more]

Publication: 1/4

Similar Datasets

2019-08-12 | BIOMD0000000787 | BioModels
| GSE111244 | GEO
2012-12-03 | E-GEOD-35330 | ArrayExpress
| GSE82160 | GEO
2016-11-18 | E-MTAB-5069 | ArrayExpress
2017-02-07 | MSV000080532 | MassIVE
2008-06-12 | E-GEOD-3054 | ArrayExpress
2006-08-04 | GSE3054 | GEO
2015-08-04 | E-GEOD-55510 | ExpressionAtlas
2014-03-04 | E-GEOD-55512 | ArrayExpress